Brand new naloxone window stickers will be popping up across Scotland any day now!

The window clings with the well-known ‘save someone’ logo will be provided to local naloxone leads who will distribute to services in their health board area that have naloxone available for use in an emergency. Most of these services will have naloxone available to take home as well. The ‘save someone’ logo was established in 2012 and has been used by colleagues and agencies internationally to promote the life-saving medication.

Continue reading

COVID-19 Guidance for Naloxone Kit Distribution (Toronto, Canada)

The intersecting drug toxicity and COVID-19 crises are creating challenges for harm reduction and naloxone programs, requiring us to adapt our practice in order to maintain the health of clients, the community and staff. Naloxone distribution remains a vital lifesaving service. The ways in which programs are conducted must take into consideration up-to-date information about COVID-19, and related infection prevention and control recommendations.

Continue reading

Book: OD Naloxone and the Politics of Overdose

The history of an unnatural disaster-drug overdose-and the emergence of naloxone as a social and technological solution. For years, drug overdose was unmentionable in polite society. OD was understood to be something that took place in dark alleys-an ugly death awaiting social deviants-neither scientifically nor clinically interesting. But over the last several years, overdose prevention has become the unlikely object of a social movement, powered by the miracle drug naloxone.

Continue reading

Saving Lives: Best practice guidance on the provision of naloxone

Release have developed best practice guidance for the provision of naloxone. Building on the findings from Release’s research on naloxone in England, Release hosted the Naloxone Steering Group 2019 in April 2019, in partnership with the National Addiction Centre at King’s College London. The objective of the steering group was to get key stakeholders together for a day to discuss some of the main aspects of naloxone provision in the UK and to produce guidelines on the provision of naloxone for people who might experience or witness an opioid overdose.

Continue reading

This website has been made possible through the provision of an arm length/unrestricted educational grant from Ethypharm. Ethypharm do not control and are not liable for any of the content placed, or any of the claims that may be made, on this site.

HIT